- SNS-101 initial Phase 1 clinical data presented at SITC demonstrate potential best-in-class safety and...
- Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.